Active Ingredient(s): Aprepitant
FDA Approved: * November 9, 2017
Pharm Company: * HERON THERAPS INC
Category: Cancer

Aprepitant, sold under the brand name Emend among others, is a medication used to prevent chemotherapy-induced nausea and vomiting (CINV) and to prevent postoperative nausea and vomiting.[1] It may be used together with ondansetron and dexamethasone.[1] It is taken by mouth.[1] Common side effects include tiredness, loss of appetite, diarrhea, abdominal pain, hiccups, itchiness, pneumonia, and blood pressure changes.[1] Other sev... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Cinvanti 130 mg/18ml Intravenous Injection, Emulsion
NDC: 47426-201
Heron Therapeutics

Related Brands

Drugs with the same active ingredients